The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics (Q37820898)

From Wikidata

Jump to navigation Jump to search

scientific article published on 14 December 2010

Language	Label	Description	Also known as
English	The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics	scientific article published on 14 December 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

1 reference

Europe PubMed Central

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

gastroenterology

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Salvatore Cucchiara

2

0 references

William Jeffery Sandborn

7

object named as

William J Sandborn

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

author name string

Uma Mahadevan

1

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Jeffrey S Hyams

3

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Flavio Steinwurz

4

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

F Nuti

5

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Simon P L Travis

6

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Jean-Frederio Colombel

8

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

language of work or name

0 references

publication date

14 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

The American Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

106

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

214-23; quiz 224

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Female fertility and childbirth after ileal pouch-anal anastomosis for ulcerative colitis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Inflammatory bowel disease: a controlled study of late pregnancy outcome

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Disease activity in pregnant women with Crohn's disease and birth outcomes: a regional Danish cohort study

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Placental transport of immunoglobulin G.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Absence of infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn's disease before and after delivery

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Infliximab and semen quality in men with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Infliximab delays but does not avoid the need for surgery in treatment-resistant pediatric Crohn' disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

A prospective study of the efficacy and tolerance of a chimeric antibody to tumor necrosis factors (remicade) in severe pediatric crohn disease.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Infliximab therapy in 30 patients with refractory pediatric crohn disease with and without fistulas in The Netherlands

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Infliximab dependency in pediatric Crohn's disease: long-term follow-up of an unselected cohort

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Use of infliximab in the treatment of Crohn's disease in children and adolescents

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Infliximab therapy in pediatric Crohn's pouchitis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Use of infliximab in pediatric patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Safety and steroid-sparing experience using infliximab for Crohn's disease at a pediatric inflammatory bowel disease center

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Infliximab dependency in a national cohort of children with Crohn's disease.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Efficacy of infliximab in pediatric Crohn's disease: a randomized multicenter open-label trial comparing scheduled to on demand maintenance therapy

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Safety and efficacy of adalimumab in pediatric patients with Crohn disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Short-term response to adalimumab in childhood inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Efficacy of adalimumab in moderate-to-severe pediatric Crohn's disease.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (RESEAT) in pediatric Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Natalizumab therapy for moderate to severe Crohn disease in adolescents

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Infliximab as a novel therapy for pediatric ulcerative colitis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Infliximab in pediatric ulcerative colitis: two-year follow-up

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Infliximab efficacy in pediatric ulcerative colitis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Infliximab for pediatric ulcerative colitis: a retrospective Italian multicenter study.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Outcome following infliximab therapy in children with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Height and occupational success: a review and critique

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Psychological and emotional development, intellectual capabilities, and body image in short normal children

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Growth retardation in pediatric Crohn's disease: pathogenesis and interventions

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Retrospective case review of pediatric patients with uveitis treated with infliximab

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Infliximab for juvenile idiopathic arthritis-associated uveitis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Adalimumab in the therapy of uveitis in childhood

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Infections and IBD.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Risk factors for opportunistic infections in patients with inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Risks and benefits of infliximab for the treatment of Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease: update

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale?

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Pediatric inflammatory bowel diseases and the risk of lymphoma: should we revise our treatment strategies?

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Infusion reactions to infliximab in children and adolescents: frequency, outcome and a predictive model

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Premedication and infusion reactions with infliximab: results from a pediatric inflammatory bowel disease consortium

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Infliximab therapy in children and adolescents with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Incidence and clinical significance of immunogenicity to infliximab in Crohn's disease: a critical systematic review

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's Disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Guidelines for immunizations in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.464

21 January 2018

Identifiers

10.1038/AJG.2010.464

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

release_7wkkffge3zeafbdk2yaykheriy

1 reference

https://api.fatcat.wiki/v0/release/7wkkffge3zeafbdk2yaykheriy

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37820898&oldid=2097500237"